Bendamustine/Bortezomib/Dexamethasone Regimen

Preferred Label : Bendamustine/Bortezomib/Dexamethasone Regimen;

NCIt synonyms : Treanda/Velcade/Dexamethasone; BVD; Bendamustine-Bortezomib-Dexamethasone; Bendamustine/Bortezomib/Dexamethasone; Bendamustine-Bortezomib-Dexamethasone Regimen;

NCIt related terms : BBD;

NCIt definition : A regimen consisting of bendamustine, bortezomib and dexamethasone that is used for the treatment of plasma cell myeloma.;

NCI Metathesaurus CUI : CL523572;

Codes from synonyms : 26699;

Details

Origin ID

C136261;

UMLS CUI

C4526534;

Automatic exact mappings (from CISMeF team)
- Bundibugyo virus disease [ICD-11 Sub-sub category]
Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Bendamustine Hydrochloride [NCIt concept]
- Bortezomib [NCIt concept]
- Dexamethasone [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]
regimen_has_accepted_use_for_disease
- Multiple Myeloma [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients